Volume 23 (2024)
Volume 22 (2023)
Volume 21 (2022)
Volume 19 (2020)
Volume 18 (2019)
Volume 17 (2018)
Volume 16 (2017)
Volume 15 (2016)
Volume 14 (2015)
Volume 13 (2014)
Volume 12 (2013)
Volume 11 (2012)
Volume 10 (2011)
Original Article
Electrophysiological studies in patients with seropositive/seronegative myasthenia gravis

Zahra Vahabi; Ferdos Nazari; Farzad Fatehi; Valiolah Bayegi; Zahra Saffarian; Fatemeh Saffarian; Shahriar Nafissi

Volume 20, Issue 3 , July 2021, Pages 120-124

https://doi.org/10.18502/cjn.v20i3.7686

Abstract
  Background: Myasthenia gravis (MG) affects the neuromuscular transmission, causing fluctuating muscle weakness and fatigue. This study is carried out with the aim to study the electrophysiologic findings of different subtypes of MG referred to our center in Tehran, Iran. Methods: All patients with MG ...  Read More

Original Article
Evaluation of rivaroxaban versus warfarin for the treatment of cerebral vein thrombosis: A case-control blinded study

Fariborz Khorvash; Mohammad Javad Farajpour-Khanaposhtani; Helia Hemasian; Mohammad Saadatnia

Volume 20, Issue 3 , July 2021, Pages 125-130

https://doi.org/10.18502/cjn.v20i3.7687

Abstract
  Background: Anticoagulation therapy following cerebral vein thrombosis (CVT) can improve mortality and morbidity. Vitamin K antagonists are currently the routine oral anticoagulant used for CVT; while by introduction of rivaroxaban, a direct factor Xa inhibitor, the attentions have been deviated toward ...  Read More

Original Article
Whole grains and legumes consumption in association with neuromyelitis optica spectrum disorder odds

Nasim Rezaeimanesh; Shadi Ariyanfar; Mohammad Ali Sahraian; Abdorreza Naser Moghadasi; Zeinab Ghorbani; Soodeh Razegh-Jahromi

Volume 20, Issue 3 , July 2021, Pages 131-138

https://doi.org/10.18502/cjn.v20i3.7688

Abstract
  Background: The environmental risk factors of neuromyelitis optica spectrum disorder (NMOSD) are not fully specified.Regarding the evidence on the possible protective effects of whole grains and legumes against inflammatory disorders, we examined the association between the mentioned dietary components ...  Read More

Original Article
Prevalence of coronavirus disease 2019 in patients with neuromyelitis optica in Isfahan, Iran, and a review on recent reports and literature

Masoud Etemadifar; Mehri Salari; Zahra Aminzade; Sara Ebrahimi; Sepand Tehrani-Fateh

Volume 20, Issue 3 , July 2021, Pages 139-145

https://doi.org/10.18502/cjn.v20i3.7689

Abstract
  Background: Despite many studies, it is still unclear how patients with neuromyelitis optica spectrum disorder (NMOSD) would respond to coronavirus disease 2019 (COVID-19). We conducted a research on prevalence of COVID-19 in patients with NMOSD in Isfahan, Iran. We have also reviewed the recent publications ...  Read More

Original Article
Cladribine tablets are a cost-effective strategy in high-disease activity relapsing multiple sclerosis patients in Iran

Nayyereh Ayati; Lora Fleifel; Shahdak Sharifi; Mohammad Sahraian; Shekoufeh Nikfar

Volume 20, Issue 3 , July 2021, Pages 146-153

https://doi.org/10.18502/cjn.v20i3.7690

Abstract
  Background: Cladribine tablets are the foremost oral immune-reconstitution therapy for high disease activity relapsing multiple sclerosis (HDA-RMS). We aimed to assess the cost-effectiveness of cladribine tablets compared to natalizumab in patients with HDA-RMS in Iran. Methods: A 5-year cohort-based ...  Read More

Original Article
Cost-effectiveness of ocrelizumab for treatment of Iranian patients with relapsing multiple sclerosis

Nayyereh Ayati; Saeed Taheri; Mohammad Ali Sahraian; Shekoufeh Nikfar

Volume 20, Issue 3 , July 2021, Pages 154-161

https://doi.org/10.18502/cjn.v20i3.7691

Abstract
  Background: The current study desired to conduct an economic analysis on ocrelizumab (OCR), a new relapsing multiple sclerosis (RMS) treatment strategy, in comparison to natalizumab (NTL), as one of the mostly-used disease-modifying therapies (DMTs) in Iran. Methods: A 31-health-state Markov model, based ...  Read More

Original Article
Myasthenia gravis and coronavirus disease 2019: A report from Iran

Masoud Etemadifar; Mahsa Akafzadeh-Savari; Mehri Salari; Amirhossein Akhavan Sigari; Sara Ebrahimi-Pelarti; Nahad Sedaghat; Koorosh Etemad

Volume 20, Issue 3 , July 2021, Pages 162-165

https://doi.org/10.18502/cjn.v20i3.7692

Abstract
  Background: Coronavirus disease 2019 (COVID-19) is spreading rapidly and has affected millions of people worldwide. Comorbid diseases have complicated the course of infection and increased mortality. Myasthenia gravis (MG) affects the neuromuscular junctions (NMJs) and can compromise respiratory muscle ...  Read More

Review Article
Environmental risk factors of multiple sclerosis in the Middle East and North Africa region: A systematic review

Hossein Maroufi; Seyyed Hosein Mortazavi; Mohammad Ali Sahraian; Sharareh Eskandarieh

Volume 20, Issue 3 , July 2021, Pages 166-184

https://doi.org/10.18502/cjn.v20i3.7693

Abstract
  Background: The environmental factors play a role as risk factors of multiple sclerosis (MS). This study aimed at gathering environmental risk factors of MS in the Middle East and North Africa (MENA). Methods: We used MEDLINE and EMBASE databases by a systematic review method. Out of a total of 123 studies, ...  Read More